An Inquiry Into the ImClone Cancer-drug Story PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download An Inquiry Into the ImClone Cancer-drug Story PDF full book. Access full book title An Inquiry Into the ImClone Cancer-drug Story by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Download full books in PDF and EPUB format.
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 770
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 770
Get Book Here
Book Description
Author: Alex Prud'homme
Publisher: Harper Collins
ISBN: 0061865621
Category : Business & Economics
Languages : en
Pages : 438
Get Book Here
Book Description
"It began with a promising cancer drug, the brainchild of a gifted researcher, and grew into an insider trading scandal that ensnared one of America's most successful women. The story of ImClone Systems and its "miracle" cancer drug, Erbitux, is the quintessential business saga of the late 1990s. It's the story of big money and cutting-edgescience, celebrity, greed, and slipshod business practices; the story of biotech hype and hope and every kind of excess. At the center of it all stands a single, enigmatic figure named Sam Waksal. A brilliant, mercurial, and desperate-to-be-liked entrepreneur, Waksal was addicted to the trappings of wealth and fame that accrued to a darling of the stock market and the overheated atmosphere of biotech IPOs. At the height of his stardom, Waksal hobnobbed with Martha Stewart in New York and Carl Icahn in the Hamptons, hosted parties at his fabulous art-filled loft, and was a fixture in the gossip columns. He promised that Erbitux would "change oncology," and would soon be making $1 billion a year. But as Waksal partied late into the night, desperate cancer patients languished, waiting for his drug to come to market. When the FDA withheld approval of Erbitux, the charming scientist who had always stayed just one step ahead of bankruptcy panicked and desperately tried to cash in his stock before the bad news hit Wall Street. Waksal is now in jail, the first of the Enron-era white-collar criminals to be sentenced. Yet his cancer drug has proved more durable than his evanescent profits. Erbitux remains promising, the leading example of a new way to fight cancer, and patients and investors hope it will be available soon.
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 780
Get Book Here
Book Description
Author: Clifton Leaf
Publisher: Simon and Schuster
ISBN: 1476739986
Category : History
Languages : en
Pages : 513
Get Book Here
Book Description
A decade ago Leaf, a cancer survivor himself, began to investigate why we had made such limited progress fighting this terrifying disease. The result is a gripping narrative that reveals why the public's immense investment in research has been badly misspent, why scientists seldom collaborate and share their data, why new drugs are so expensive yet routinely fail, and why our best hope for progress-- brilliant young scientists-- are now abandoning the search for a cure.
Author: United States. Congress. House. Committee on Energy and Commerce
Publisher:
ISBN:
Category : Energy policy
Languages : en
Pages : 318
Get Book Here
Book Description
Author:
Publisher: DIANE Publishing
ISBN: 1428917926
Category :
Languages : en
Pages : 314
Get Book Here
Book Description
Author:
Publisher: Government Printing Office
ISBN:
Category :
Languages : en
Pages : 1412
Get Book Here
Book Description
Author: Clifton Leaf
Publisher: Simon and Schuster
ISBN: 1476739994
Category : History
Languages : en
Pages : 512
Get Book Here
Book Description
A decade ago Leaf, a cancer survivor himself, began to investigate why we had made such limited progress fighting this terrifying disease. The result is a gripping narrative that reveals why the public's immense investment in research has been badly misspent, why scientists seldom collaborate and share their data, why new drugs are so expensive yet routinely fail, and why our best hope for progress-- brilliant young scientists-- are now abandoning the search for a cure.
Author: United States. Congress. House. Permanent Select Committee on Intelligence
Publisher:
ISBN:
Category : Intelligence officers
Languages : en
Pages : 56
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 720
Get Book Here
Book Description
